Jump to main content
Jump to site search


BODIPY derivatives as light-induced free radical generators for hypoxic cancer treatment

Author affiliations

Abstract

In photodynamic therapy, hypoxic conditions greatly impede the treatment efficacy due to the high dependence on oxygen for the generation of toxic reactive oxygen species (ROS). Accordingly, it is imperative to develop a novel oxygen-independent therapeutic strategy. Herein, the novel organic self-assembly of distyryl-diethylamine-borondipyrromethene nanoparticles (NBDP NPs) was designed to generate oxygen-independent alkyl radicals upon near-infrared light (NIR) irradiation, in which the borondipyrromethene (BODIPY) unit with a high photothermal conversion efficiency of 54% acts as an alkyl radical initiator. The experiments in vitro have proved that NBDP NPs can effectively generate alkyl radicals under hypoxic conditions and induce apoptosis. The weak acidic environment of the lysosome can further accelerate the generation of alkyl radicals. The obtained data in vivo also verify that the generated free alkyl radicals can inhibit the growth of tumor. This combination of photothermal therapy (PTT) with free radicals provides a new platform for hypoxic cancer therapy.

Graphical abstract: BODIPY derivatives as light-induced free radical generators for hypoxic cancer treatment

Back to tab navigation

Supplementary files

Publication details

The article was received on 10 Apr 2019, accepted on 09 May 2019 and first published on 15 May 2019


Article type: Paper
DOI: 10.1039/C9TB00694J
J. Mater. Chem. B, 2019, Advance Article

  •   Request permissions

    BODIPY derivatives as light-induced free radical generators for hypoxic cancer treatment

    N. Song, Y. Li, L. Chen, X. Hu and Z. Xie, J. Mater. Chem. B, 2019, Advance Article , DOI: 10.1039/C9TB00694J

Search articles by author

Spotlight

Advertisements